EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Penetrance, cancer incidence and survival in HFE haemochromatosis—A population‐based cohort study

Benedikt Schaefer, Lorenz M Pammer, Bernhard Pfeifer, Sabrina Neururer, Maria R Troppmair, Marlene Panzer, Sonja Wagner, Elke Pertler, Christian Gieger, Florian Kronenberg, Claudia Lamina, Herbert Tilg und 1 weitere

Liver International · 2024

DOI: 10.1111/liv.15797 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Liver International, 2024. Verfasst von Benedikt Schaefer und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine I, Gastroenterology, Hepatology and Endocrinology, Medical University of Innsbruck, Innsbruck, Austria. Hauptthemen laut MEDLINE: Hemochromatosis, Carcinoma, Hepatocellular, Iron Overload, Liver Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Federal Ministry for Digital and Economic Affairs, Christian Doppler Forschungsgesellschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Haemochromatosis is characterized by progressive iron overload affecting the liver and can cause cirrhosis and hepatocellular carcinoma. Most haemochromatosis patients are homozygous for p.C282Y in HFE , but only a minority of individuals with this genotype will develop the disease. The aim was to assess the penetrance of iron overload, fibrosis, hepatocellular carcinoma and life expectancy.

Methods

A total of 8839 individuals from the Austrian region of Tyrol were genotyped for the p.C282Y variant between 1997 and 2021. Demographic, laboratory parameters and causes of death were assessed from health records. Penetrance, survival, and cancer incidence were ascertained from diagnosed cases, insurance‐ and cancer registry data. Outcomes were compared with a propensity score‐matched control population.

Results

Median age at diagnosis in 542 p.C282Y homozygous individuals was 47.8 years (64% male). At genotyping, the prevalence of iron overload was 55%. The cumulative penetrance of haemochromatosis defined as the presence of provisional iron overload was 24.2% in males and 10.5% in females aged 60 years or younger. Among p.C282Y homozygotes of the same ages, the cumulative proportion of individuals without fibrosis (FIB‐4 score < 1.3) was 92.8% in males and 96.7% in females. Median life expectancy was reduced by 6.8 years in individuals homozygous for p.C282Y when compared with population‐matched controls ( p = .001). Hepatocellular carcinoma incidence was not significantly higher in p.C282Y homozygotes than in controls matched for age and sex.

Conclusion

Reduced survival and the observed age‐dependent increase in penetrance among p.C282Y homozygotes call for earlier diagnosis of haemochromatosis to prevent complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemochromatosisCarcinoma, HepatocellularIron OverloadLiver NeoplasmsFemaleHumansMaleMiddle AgedPenetranceCohort StudiesIncidenceHistocompatibility Antigens Class IHemochromatosis ProteinHomozygoteLiver CirrhosisMutation

Stichwörter der Autor:innen

FIB-4fibrosishepatocellular carcinomairon overloadmalignancy

Substanzen

Histocompatibility Antigens Class IHemochromatosis ProteinHFE protein, human

Autor:innen und Institutionen

  • Department of Medicine I, Gastroenterology, Hepatology and Endocrinology, Medical University of Innsbruck, Innsbruck, Austria.
  • Division for Digital Medicine and Telehealth, UMIT TIROL-Private University for Health Sciences and Health Technology, Hall (Tyrol), Austria.
  • Tyrolean Federal Institute for Integrated Care, Tirol Kliniken Gmbh, Innsbruck, Austria.
  • Christian Doppler Laboratory for Iron and Phosphate Biology, Medical University of Innsbruck, Innsbruck, Austria.
  • Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
  • Research Unit of Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.

ORCID-Profile: Heinz Zoller

Förderung

  • Austrian Federal Ministry for Digital and Economic Affairs
  • Christian Doppler Forschungsgesellschaft

Zitieren

APA

Schaefer, B., Pammer, L. M., Pfeifer, B., Neururer, S., Troppmair, M. R., Panzer, M., Wagner, S., Pertler, E., Gieger, C., Kronenberg, F., Lamina, C., Tilg, H., & Zoller, H. (2024). Penetrance, cancer incidence and survival in HFE haemochromatosis—A population‐based cohort study. Liver International. https://doi.org/10.1111/liv.15797

Vancouver

Schaefer B, Pammer LM, Pfeifer B, Neururer S, Troppmair MR, Panzer M, et al. Penetrance, cancer incidence and survival in HFE haemochromatosis—A population‐based cohort study. Liver International. 2024. doi:10.1111/liv.15797

BibTeX
@article{Schaefer2024,
  author = {Schaefer, Benedikt and Pammer, Lorenz M and Pfeifer, Bernhard and Neururer, Sabrina and Troppmair, Maria R and Panzer, Marlene and Wagner, Sonja and Pertler, Elke and Gieger, Christian and Kronenberg, Florian and Lamina, Claudia and Tilg, Herbert and Zoller, Heinz},
  title = {Penetrance, cancer incidence and survival in HFE haemochromatosis—A population‐based cohort study},
  journal = {Liver International},
  year = {2024},
  doi = {10.1111/liv.15797}
}
Kostenlos starten →